SC
AGN

Searle & Co’s Allergan plc AGN Stock Holding History

Searle & Co’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-9,105
Closed -$1.61M – 144
2020
Q1 		$1.61M Hold
9,105
– – 1.14% 31
2019
Q4 		$1.74M Buy
9,105
+170
+2% +$30.7K 0.96% 37
2019
Q3 		$1.5M Sell
8,935
-250
-3% -$40.7K 0.89% 40
2019
Q2 		$1.54M Hold
9,185
– – 0.94% 37
2019
Q1 		$1.34M Hold
9,185
– – 0.84% 41
2018
Q4 		$1.23M Sell
9,185
-1,900
-17% -$311K 0.86% 41
2018
Q3 		$2.11M Hold
11,085
– – 1.24% 31
2018
Q2 		$1.85M Sell
11,085
-500
-4% -$80.3K 1.17% 33
2018
Q1 		$1.95M Hold
11,585
– – 1.27% 27
2017
Q4 		$1.9M Hold
11,585
– – 1.19% 27
2017
Q3 		$2.37M Hold
11,585
– – 1.57% 18
2017
Q2 		$2.82M Hold
11,585
– – 1.93% 9
2017
Q1 		$2.77M Hold
11,585
– – 1.94% 7
2016
Q4 		$2.43M Sell
11,585
-107
-0.9% -$22.2K 2.02% 8
2016
Q3 		$2.76M Buy
11,692
+10,292
+735% +$2.52M 2.4% 8
2016
Q2 		$331K Sell
1,400
-8,172
-85% -$1.88M 3.36% 9
2016
Q1 		$2.57M Hold
9,572
– – 2.36% 10
2015
Q4 		$2.94M Buy
9,572
+500
+6% +$149K 2.82% 6
2015
Q3 		$2.47M Sell
9,072
-500
-5% -$154K 2.53% 7
2015
Q2 		$2.9M Hold
9,572
– – 2.42% 6
2015
Q1 		$2.85M Hold
9,572
– – 2.45% 6
2014
Q4 		$2.46M Buy
+9,572
New +$2.39M 2.08% 7

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Searle & Co's AGN Position: Q2 2020 in Review

Searle & Co sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 9,105 shares — an estimated $1.61M sold.

Searle & Co first reported a position in AGN in Q4 2014 and held it in 22 quarters. The position peaked at $2.94M in Q4 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Searle & Co reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Searle & Co sold 9,105 Allergan plc shares in Q2 2020, an estimated $1.61M.
  • Searle & Co first reported a position in Allergan plc in Q4 2014 and held it in 22 quarters.
  • Searle & Co's Allergan plc position peaked at $2.94M in Q4 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Searle & Co's 13F filing for Q2 2020, filed 3 Aug 2020.